402 related articles for article (PubMed ID: 31791436)
21. Autoimmune Encephalopathies and Dementias.
McKeon A
Continuum (Minneap Minn); 2016 Apr; 22(2 Dementia):538-58. PubMed ID: 27042907
[TBL] [Abstract][Full Text] [Related]
22. Autoimmune Epilepsy.
Husari KS; Dubey D
Neurotherapeutics; 2019 Jul; 16(3):685-702. PubMed ID: 31240596
[TBL] [Abstract][Full Text] [Related]
23. Autoimmune Encephalitis: Current Knowledge on Subtypes, Disease Mechanisms and Treatment.
Nissen MS; Ryding M; Meyer M; Blaabjerg M
CNS Neurol Disord Drug Targets; 2020; 19(8):584-598. PubMed ID: 32640967
[TBL] [Abstract][Full Text] [Related]
24. Neural Autoantibodies in Cerebrospinal Fluid and Serum in Clinical High Risk for Psychosis, First-Episode Psychosis, and Healthy Volunteers.
Bien CG; Rohleder C; Mueller JK; Bien CI; Koethe D; Leweke FM
Front Psychiatry; 2021; 12():654602. PubMed ID: 33841216
[TBL] [Abstract][Full Text] [Related]
25. Anti-leucine-rich Glioma-inactivated-1 Encephalitis with Faciobrachial Dystonic Seizures and Behavioral Problems: A Case Report.
Adhikari A; Subedi RC; Acharya S; Paudel R
JNMA J Nepal Med Assoc; 2020 Jul; 58(227):487-490. PubMed ID: 32827010
[TBL] [Abstract][Full Text] [Related]
26. Clinical characteristics of Leucine-rich glioma-inactivated protein 1 antibody-mediated autoimmune encephalitis in a 6-year-old girl: case report and literature reviews.
Chen L; Su T; Liu Y
BMC Neurol; 2023 Jun; 23(1):253. PubMed ID: 37391712
[TBL] [Abstract][Full Text] [Related]
27. Antibodies to the GABA(B) receptor in limbic encephalitis with seizures: case series and characterisation of the antigen.
Lancaster E; Lai M; Peng X; Hughes E; Constantinescu R; Raizer J; Friedman D; Skeen MB; Grisold W; Kimura A; Ohta K; Iizuka T; Guzman M; Graus F; Moss SJ; Balice-Gordon R; Dalmau J
Lancet Neurol; 2010 Jan; 9(1):67-76. PubMed ID: 19962348
[TBL] [Abstract][Full Text] [Related]
28. Emerging psychiatric syndromes associated with antivoltage-gated potassium channel complex antibodies.
Prüss H; Lennox BR
J Neurol Neurosurg Psychiatry; 2016 Nov; 87(11):1242-1247. PubMed ID: 27435086
[TBL] [Abstract][Full Text] [Related]
29. A rare case of anti-LGI1 limbic encephalitis with concomitant positive NMDAR antibodies.
Ji T; Huang Z; Lian Y; Wang C; Zhang Q; Li J
BMC Neurol; 2020 Sep; 20(1):336. PubMed ID: 32894089
[TBL] [Abstract][Full Text] [Related]
30. Typical clinical and imaging manifestations of encephalitis with anti-γ-aminobutyric acid B receptor antibodies: clinical experience and a literature review.
Si Z; Wang A; Liu J; Zhang Z; Hu K
Neurol Sci; 2019 Apr; 40(4):769-777. PubMed ID: 30671737
[TBL] [Abstract][Full Text] [Related]
31. [Autoimmune encephalitis-An update].
Heine J; Duchow A; Rust R; Paul F; Prüß H; Finke C
Nervenarzt; 2023 Jun; 94(6):525-537. PubMed ID: 36515716
[TBL] [Abstract][Full Text] [Related]
32. Antibody-Mediated Autoimmune Encephalitis in Childhood.
Brenton JN; Goodkin HP
Pediatr Neurol; 2016 Jul; 60():13-23. PubMed ID: 27343023
[TBL] [Abstract][Full Text] [Related]
33. Anti-neuronal anti-bodies in patients with early psychosis.
Mantere O; Saarela M; Kieseppä T; Raij T; Mäntylä T; Lindgren M; Rikandi E; Stoecker W; Teegen B; Suvisaari J
Schizophr Res; 2018 Feb; 192():404-407. PubMed ID: 28461116
[TBL] [Abstract][Full Text] [Related]
34. Pediatric GAD-65 Autoimmune Encephalitis: Assessing Clinical Characteristics and Response to Therapy With a Novel Assessment Scale.
Harmon A; Stingl C; Rikhi A; Tran L; Pizoli C; Malinzak M; Van Mater H
Pediatr Neurol; 2022 Mar; 128():25-32. PubMed ID: 35032887
[TBL] [Abstract][Full Text] [Related]
35. Clinical Spectrum of Encephalitis Associated With Antibodies Against the α-Amino-3-Hydroxy-5-Methyl-4-Isoxazolepropionic Acid Receptor: Case Series and Review of the Literature.
Joubert B; Kerschen P; Zekeridou A; Desestret V; Rogemond V; Chaffois MO; Ducray F; Larrue V; Daubail B; Idbaih A; Psimaras D; Antoine JC; Delattre JY; Honnorat J
JAMA Neurol; 2015 Oct; 72(10):1163-9. PubMed ID: 26280228
[TBL] [Abstract][Full Text] [Related]
36. Autoimmune encephalitis.
Goodfellow JA; Mackay GA
J R Coll Physicians Edinb; 2019 Dec; 49(4):287-294. PubMed ID: 31808454
[TBL] [Abstract][Full Text] [Related]
37. Extreme delta - With or without brushes: A potential surrogate marker of disease activity in anti-NMDA-receptor encephalitis.
Steriade C; Hantus S; Moosa ANV; Rae-Grant AD
Clin Neurophysiol; 2018 Oct; 129(10):2197-2204. PubMed ID: 29580710
[TBL] [Abstract][Full Text] [Related]
38. Anti-NMDAR autoimmune encephalitis.
Miya K; Takahashi Y; Mori H
Brain Dev; 2014 Sep; 36(8):645-52. PubMed ID: 24211006
[TBL] [Abstract][Full Text] [Related]
39. Updates in the Diagnosis and Treatment of Paraneoplastic Neurologic Syndromes.
Grativvol RS; Cavalcante WCP; Castro LHM; Nitrini R; Simabukuro MM
Curr Oncol Rep; 2018 Nov; 20(11):92. PubMed ID: 30415318
[TBL] [Abstract][Full Text] [Related]
40. What is autoimmune encephalitis-associated epilepsy? Proposal of a practical definition.
Rada A; Bien CG
Epilepsia; 2023 Sep; 64(9):2249-2255. PubMed ID: 37353891
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
